Wilms Tumour

Gene: BRCA2

Green List (high evidence)

BRCA2 (BRCA2, DNA repair associated)
EnsemblGeneIds (GRCh38): ENSG00000139618
EnsemblGeneIds (GRCh37): ENSG00000139618
OMIM: 600185, Gene2Phenotype
BRCA2 is in 22 panels

1 review

Chirag Patel (Genetic Health Queensland)

Green List (high evidence)

ClinGen definitive. Wilms tumour reported in condition.
Sources: Expert list, Expert Review
Created: 26 Sep 2024, 12:48 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Wilms tumor, MONDO:0006058; Fanconi anemia complementation group D1,MONDO:0011584; Fanconi anemia, complementation group D1, MIM#605724

History Filter Activity

9 Oct 2024, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: brca2 has been classified as Green List (High Evidence).

26 Sep 2024, Gel status: 3

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: brca2 has been classified as Green List (High Evidence).

26 Sep 2024, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Chirag Patel (Genetic Health Queensland)

gene: BRCA2 was added gene: BRCA2 was added to Wilms Tumour. Sources: Expert list,Expert Review Mode of inheritance for gene: BRCA2 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: BRCA2 were set to Wilms tumor, MONDO:0006058; Fanconi anemia complementation group D1,MONDO:0011584; Fanconi anemia, complementation group D1, MIM#605724 Review for gene: BRCA2 was set to GREEN